StarFlex Past Earnings Performance
Past criteria checks 0/6
StarFlex has been growing earnings at an average annual rate of 18.5%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been declining at an average rate of 1.8% per year.
Key information
18.5%
Earnings growth rate
21.0%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | -1.8% |
| Return on equity | -23.3% |
| Net Margin | -20.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How StarFlex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 70,701 | -14,741 | 9,182 | 85 |
| 30 Sep 23 | 71,190 | -7,667 | 8,665 | 78 |
| 30 Jun 23 | 84,290 | 1,121 | 10,020 | 74 |
| 31 Mar 23 | 94,105 | 5,749 | 10,375 | 77 |
| 31 Dec 22 | 104,073 | 6,548 | 11,826 | 81 |
| 30 Sep 22 | 106,361 | 16,589 | 14,436 | 84 |
| 30 Jun 22 | 98,971 | 7,767 | 13,489 | 88 |
| 31 Mar 22 | 90,140 | -49 | 13,319 | 80 |
| 31 Dec 21 | 84,992 | 2,389 | 12,267 | 99 |
| 30 Sep 21 | 78,066 | -6,109 | 9,879 | 112 |
| 30 Jun 21 | 73,053 | -5,442 | 9,194 | 122 |
| 31 Mar 21 | 65,748 | -2,421 | 9,408 | 138 |
| 31 Dec 20 | 68,107 | -6,874 | 9,844 | 139 |
| 30 Sep 20 | 75,023 | -9,132 | 10,118 | 147 |
| 30 Jun 20 | 79,383 | -9,004 | 10,555 | 205 |
| 31 Mar 20 | 91,003 | -9,925 | 10,151 | 255 |
| 31 Dec 19 | 92,737 | -7,767 | 10,032 | 307 |
| 30 Sep 19 | 98,152 | -4,103 | 10,622 | 350 |
| 30 Jun 19 | 98,812 | -1,207 | 10,419 | 378 |
| 31 Mar 19 | 96,516 | 529 | 9,504 | 388 |
| 31 Dec 18 | 95,097 | -2,226 | 9,001 | 381 |
| 30 Sep 18 | 91,081 | -5,462 | 8,609 | 377 |
| 30 Jun 18 | 89,906 | -8,126 | 8,423 | 351 |
| 31 Mar 18 | 89,399 | -8,013 | 8,794 | 341 |
| 31 Dec 17 | 86,988 | -6,605 | 8,597 | 353 |
| 30 Sep 17 | 82,942 | 1,690 | 7,845 | 340 |
| 30 Jun 17 | 81,898 | 2,993 | 7,429 | 364 |
| 31 Mar 17 | 83,391 | 5,363 | 7,155 | 382 |
| 31 Dec 16 | 85,306 | 6,868 | 7,165 | 380 |
| 30 Sep 16 | 85,947 | 910 | 6,989 | 400 |
| 30 Jun 16 | 86,678 | 2,037 | 7,109 | 374 |
| 31 Mar 16 | 82,033 | -384 | 7,180 | 336 |
| 31 Dec 15 | 79,180 | -2,122 | 7,379 | 313 |
| 30 Sep 15 | 80,202 | 4,437 | 6,775 | 308 |
| 30 Jun 15 | 81,905 | 962 | 7,245 | 296 |
| 31 Mar 15 | 85,872 | 14 | 8,533 | 316 |
| 31 Dec 14 | 87,819 | 233 | 8,600 | 396 |
| 30 Sep 14 | 86,665 | -2,631 | 8,978 | 398 |
| 30 Jun 14 | 86,121 | -571 | 8,948 | 391 |
| 31 Mar 14 | 89,051 | 1,977 | 7,792 | 344 |
| 31 Dec 13 | 100,141 | 1,102 | 8,723 | 258 |
| 30 Sep 13 | 141,360 | -10,525 | 12,408 | 214 |
| 30 Jun 13 | 184,069 | -10,309 | 12,835 | 213 |
Quality Earnings: A115570 is currently unprofitable.
Growing Profit Margin: A115570 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A115570 is unprofitable, but has reduced losses over the past 5 years at a rate of 18.5% per year.
Accelerating Growth: Unable to compare A115570's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A115570 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-15.5%).
Return on Equity
High ROE: A115570 has a negative Return on Equity (-23.35%), as it is currently unprofitable.